Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD81 | P60033 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | EP300 | Q09472 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1765494 | 0.89 | CD81 (0.44) | CD81PPARGTBXAS1BACE1PTGS1 | |
| SCHEMBL129059 | 0.89 | CD81 (0.44) | CD81PPARGTBXAS1BACE1PTGS1 | |
| Ethylene SCHEMBL11587042 | 0.84 | CD81 (0.42) | CD81PPARGTBXAS1BACE1PTGS1 | |
| Ethylene Glycol SCHEMBL29396243 | 0.82 | CD81 (0.41) | CD81PPARGTBXAS1BACE1PTGS1 | |
| SCHEMBL10952295 | 0.82 | KDM4E (0.46) | CD81KDM4EATM | |
| SCHEMBL10952301 | 0.82 | KDM4E (0.46) | CD81KDM4EATM | |
| SCHEMBL23829799 | 0.81 | CD81 (0.38) | CD81PPARGTBXAS1BACE1PTGS1 | |
| SCHEMBL7253724 | 0.81 | CD81 (0.38) | CD81PPARGTBXAS1BACE1PTGS1 | |
| SCHEMBL7253726 | 0.81 | CD81 (0.38) | CD81PPARGTBXAS1BACE1PTGS1 | |
| SCHEMBL9009800 | 0.80 | CD81 (0.40) | CD81PPARGTBXAS1BACE1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120108679-A1 | BRANCHED COPOLYMERS, COMPOSITION AND USES | UNILEVER PLC (GB) | 2012-05-03 | — | — | US | claimed |
| US-20120095110-A1 | BRANCHED POLYMER DISPERSANTS | UNILEVER PLC (GB) | 2012-04-19 | — | — | US | claimed |
| US-20120095112-A1 | BRANCHED POLYMER DISPERSANTS | UNILEVER HOUSE (GB) | 2012-04-19 | — | — | US | claimed |
| US-20120095111-A1 | BRANCHED POLYMER DISPERSANTS | UNILEVER PLC (GB) | 2012-04-19 | — | — | US | claimed |
| US-20190250510-A1 | PHOTOSENSITIVE COMPOSITION AND ORGANIC THIN-FILM TRANSISTOR | SUMITOMO CHEMICAL COMPANY, LIMITED. (JP) | 2019-08-15 | — | — | US | disclosed |
| US-10034818-B2 | Use of a benefit delivery particle for malodour benefit | CONOPCO, INC. (US) | 2018-07-31 | — | — | US | disclosed |
| EP-3148650-B1 | BENEFIT DELIVERY PARTICLE FOR TREATING SUBSTRATES | UNILEVER PLC (GB) | 2018-07-04 | — | — | EP | disclosed |
| US-9993401-B2 | Benefit delivery particle, process for preparing said particle, compositions comprising said particles and a method for treating substrates | CONOPCO, INC. (US) | 2018-06-12 | — | — | US | disclosed |
| EP-3148649-B1 | USE OF PARTICLES TO ABSORB MALODORS | UNILEVER PLC (GB) | 2017-11-29 | — | — | EP | disclosed |
| US-20170202754-A1 | BENEFIT DELIVERY PARTICLE FOR TREATING SUBSTRATES | CONOPCO, INC., D/B/A UNILEVER (US) | 2017-07-20 | — | — | US | disclosed |
| US-20170181935-A1 | USE OF A BENEFIT DELIVERY PARTICLE FOR MALODOUR BENEFIT | CONOPCO, INC., D/B/A UNILEVER (US) | 2017-06-29 | — | — | US | disclosed |
| US-20160159954-A1 | POLYDENDRONS | The Univeristy of Liverpool (GB) | 2016-06-09 | — | — | US | disclosed |
| EP-2102256-B1 | POLYMERS | UNILEVER PLC (GB) | 2012-01-25 | — | — | EP | disclosed |
| US-20110172314-A1 | AMPHIPHILIC BRANCHED POLYMERS AND THEIR USE AS EMULSIFIERS | UNILEVER N.V. (NL) | 2011-07-14 | — | — | US | disclosed |
| WO-2011029580-A1 | USE OF BRANCHED COPOLYMERS IN POLYMER BLENDS | UNILEVER PLC (GB) | 2011-03-17 | — | — | WO | disclosed |
| WO-2010089571-A1 | BRANCHED COPOLYMERS, COMPOSITIONS AND USES | UNILEVER PLC (GB) | 2010-08-12 | — | — | WO | disclosed |
| US-20100144958-A1 | POLYMERS | UNILEVER PLC (GB) | 2010-06-10 | — | — | US | disclosed |
| US-20100145001-A1 | BRANCHED ORGANIC-INORGANIC POLYMERS | UNILEVER PLC (GB) | 2010-06-10 | — | — | US | disclosed |
| US-20100130641-A1 | Polymers | UNILEVER PLC (GB) | 2010-05-27 | — | — | US | disclosed |
| EP-2128180-A1 | Amphiphilic branched polymers and their use as emulsifiers | UNILEVER N.V. (NL) | 2009-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159954-A1 | POLYDENDRONS | PARN, DSTN, DAD1 | CD81 2002/4885PPARG 4695/4885TBXAS1 2121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.